Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats

Journal of Periodontal Research

Volumn 44, Issue 2, 2009, Pages 153-160

  Queiroz Junior, C M ^a   Pacheco, C M F ^a   Maltos, K L M ^a   Caliari, M V ^a   Duarte, I D G ^a   Francischi, J N ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Campus Pampulha ^*  (Brazil)

Author keywords

Cyclo oxygenase 1; Cyclo oxygenase 2; Inflammation; Periodontal disease

Indexed keywords

4 (5 (4 CHLOROPHENYL) 3 (TRIFLUOROMETHYL) 1H PYRAZOL 1 YL)BENZENESULFONAMIDE; 4-(5-(4-CHLOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE; ARACHIDONIC ACID; CELECOXIB; INDOMETACIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; MALE; METABOLISM; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PERIODONTITIS; RAT; SPRAGUE DAWLEY RAT;

ALVEOLAR BONE LOSS; ANIMALS; ARACHIDONIC ACID; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; INDOMETHACIN; MALE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL LIGAMENT; PERIODONTITIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES;

EID: 60949102238     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01069.x     Document Type: Article

References (32)

1. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997 14 : 216 248.
2. Van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 2003 82 : 82 90.
3. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986 21 : 101 112.
4. Mitchell JÁ, Warner TD. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov 2006 5 : 75 86.
5. Smith WL, Garavito RM, Dewitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J Biol Chem 1996 271 : 33157 33160.
6. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998 18 : 7908 7916.
7. 2 by selective cyclooxygenase 2 inhibitors accounts for reduced rat leukocyte migration. Inflammation 2005 29 : 163 169.
8. 4 inhibits leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 2000 39 : 4761 4768.
9. Bezerra MM, Lima V, Alencar VBM et al. Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 2000 71 : 1009 1014.
10. Lohinai Z, Stachlewitz R, Székely AD, Fehér E, Dézsi L, Szabó C. Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis. Life Sci 2001 70 : 279 290.
11. Holzhausen M, Rossa Júnior C, Marcantonio Júnior E, Nassar PQ, Spolidório DM, Spolidório LC. Effect of selective cyclooxygenase-2 inhibition on the development of ligature-induced periodontitis in rats. J Periodontol 2002 73 : 1030 1036.
12. Li KL, Vogel R, Jeffcoat MK et al. The effect of ketoprofen creams on periodontal disease in rhesus monkeys. J Periodont Res 1996 31 : 525 532.
13. 2 antagonist prevents periodontitis in a rabbit model. Infect Immun 2006 74 : 2402 2414.
14. Sallay K, Sanavi F, Ring I, Pham P, Behling UH, Nowotny A. Alveolar bone destruction in the immunosuppressed rat. J Periodont Res 1982 17 : 263 274.
15. Pacheco CMF, Queiroz-Junior CM, Maltos KLM, Caliari MV, Rocha OA, Francischi JN. Local opioids in a model of periodontal disease in rats. Arch Oral Biol 2007 52 : 677 683.
16. Maltos KLM, Menezes GB, Caliari MV et al. Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp. Arch Oral Biol 2004 49 : 443 450.
17. Francischi JN, Chaves CT, Moura AC et al. Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation. Br J Pharmacol 2002 137 : 837 844.
18. Resende MA, Sabino GG, Candido CR, Pereira LS, Francischi JN. Local transcutaneous electrical stimulation (TENS) effects in experimental inflammatory edema and pain. Eur J Pharmacol 2004 504 : 217 222.
19. França DS, Ferreira-Alves DL, Duarte ID et al. Endogenous opioids mediate the hypoalgesia induced by selective inhibitors of cyclooxygenase 2 in rat paws treated with carrageenan. Neuropharmacology 2006 51 : 37 43.
20. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 2000 24 : 239 252.
21. Miyauchi M, Hiraoka M, Oka H et al. Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide. Arch Oral Biol 2004 49 : 739 746.
22. ElAttar TMA, Lin HS, Tira DE. Arachidonic acid metabolism in inflamed gingiva and its inhibition by anti-inflammatory drugs. J Periodontol 1984 55 : 536 539.
23. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nat New Biol 1971 231 : 232 235.
24. FitzGerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 2001 345 : 433 442.
25. 2 and IL-6 production by human gingival fibroblasts. J Periodontol 2003 74 : 1754 1763.
26. Lin SJ, Chen YL, Kuo MY, Li CL, Lu HK. Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 2005 30 : 160 167.
27. 2 and clinical parameters of chronic periodontitis. J Periodontol 2003 74 : 57 63.
28. 2 upregulates interleukin-6 production in human gingival fibroblasts. J Periodont Res 2001 36 : 80 87.
29. Smith CJ, Zhang Y, Kobolt CM et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998 95 : 13313 13318.
30. Siqueira-Junior JM, Peters RR, Brum-Fernandes AJ, Ribeiro-do-Valle R. Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice. Pharmacol Res 2003 48 : 437 443.
31. 2 release from synovitis tissue in primary osteoarthritis in vitro. Osteoarthritis Cartilage 2004 12 : 658 666.
32. 2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition. FASEB J 2006 20 : 1352 1360.